← Back to all signals
RESEARCH PAPER ANALYSIS

Early Discontinuation of Empiric Antibiotic Therapy in Children with Cancer and Febrile Neutropenia: A Narrative Review.

AI interpretation is pending for this paper.

Open original publication →
PMID41597389
JournalMedicina (Kaunas, Lithuania)
Publication Date2026-01-02
Ingested2026-08-02 12:12 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Background and Objectives: Febrile neutropenia (FN) is a potentially life-threatening complication in children undergoing cancer treatment. Immediate initiation of empirical antibiotic treatment (EAT) has improved the prognosis and outcomes of FN. Although the ideal timing for initiating EAT is clear, the optimal timing for EAT discontinuation remains debatable. Early hospital discharge (EHD) with continuation of oral antibiotics has also been proposed as an alternative strategy. This narrative review aims to present a comprehensive overview of the evidence on early discontinuation of EAT or EHD in children with FN and cancer. Materials and Methods: A comprehensive literature search was performed to identify relevant studies assessing early EAT discontinuation or EHD in children with cancer and FN. Extracted data included the safety outcomes, the benefits for the patients and the cost for healthcare systems. Results: Thirty-one studies were included; twenty-one investigated the early discontinuation of EAT and ten studies evaluated EHD. Most studies reported early discontinuation of EAT or EHD as a safe FN treatment approach with potential benefits for the patients, especially when applied to selected low-risk FN cases. Reported benefits included shorter hospitalization duration and reduced antibiotic use, with additional economic advantages in several studies. Conclusions: Early discontinuation of EAT appears to be a safe and beneficial management approach for children with FN and cancer by reducing the length of hospital stay and the duration of antibiotic use. EHD with oral therapy continuation also appears to be safe but less beneficial than early discontinuation of EAT. High-quality evidence and standardized criteria are needed to support broader implementation of these strategies in routine clinical practice.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Awareness, Accessibility, Authenticity, and Appropriateness: Multilevel Determinants of Research Engagement Among Underrepresented AYA Cancer Survivors. Cancer control : journal of the Moffitt Cancer Center 58.0 2 The Clinical Impact of End-of-Consolidation Measurable Residual Disease in High-Risk Pediatric B-Cell Acute Lymphoblastic Leukemia. Cancer control : journal of the Moffitt Cancer Center 72.4 3 Ischemic stroke as the first manifestation of acute promyelocytic. Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 60.8 4 CAR-T Versus Non-CAR-T Bridging Strategies Before Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A Systematic Review. Cureus 87.84 5 p53 and β-Catenin Expression in Gallbladder Carcinoma: Translational Insights for Pediatric Cancer Biology. Asian Pacific journal of cancer prevention : APJCP 64.4 6 Expression of miR-214 in Pediatric Acute Leukemia: Correlations with Leukemia Subtypes, Familial Predisposition, and Hepatitis B Virus Infection. Asian Pacific journal of cancer prevention : APJCP 57.5 7 Relative Survival Rates of Pediatric Patients with Solid Tumours in Khon Kaen, Thailand. Asian Pacific journal of cancer prevention : APJCP 60.02 8 A Cross-Sectional Study of Knowledge, Attitudes, and Perceptions toward HPV Vaccination Among Undergraduate Students Studying in Sarawak, Malaysia. Asian Pacific journal of cancer prevention : APJCP 59.5 9 Breast Cancer-Related Quality of Life among Women Undergoing Treatment: A Hospital-Based Study in Vietnam. Asian Pacific journal of cancer prevention : APJCP 74.84 10 Tobacco Consumption, Early Initiation, and Determinants Among School-Going Adolescents in Ranchi, Jharkhand: A Cross-Sectional Study. Asian Pacific journal of cancer prevention : APJCP 59.0 11 Case 354. Radiology 58.4 12 CAF-derived BHB modulates FXR1-Kbhb and NK-cell lipid metabolism in osteosarcoma. International journal of biological sciences 70.3 13 Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis in the Gulf Cooperation Council: a modified Delphi approach. Frontiers in immunology 63.5 14 Meridian-based traditional Chinese medicine interventions for supportive care in children, adolescents, and young adults with cancer: a systematic review and meta-analysis. Frontiers in pediatrics 85.7 15 Adipose tissue: an overlooked target of medical ionizing radiation and its metabolic consequences. Frontiers in public health 60.6 16 Navigating the immunosuppressive abyss: current hurdles and innovative breakthroughs in neoadjuvant immunotherapy for osteosarcoma. Frontiers in immunology 72.82 17 Subperiosteal lesions: a radiologic spectrum of pathologies and diagnostic considerations. Clinical imaging 55.2 18 Primary Hyperparathyroidism Presenting as a Distal Femur Pathologic Fracture in an Adolescent: A Case Report. JBJS case connector 47.9 19 Femoral Neck System and Cement Augmentation for Temporizing a Pathologic Hip Fracture in Osteosarcoma: A Case Report. JBJS case connector 49.9 20 Sexual dysfunction in women with gestational trophoblastic disease: a cross-sectional study in Recife, Pernambuco, Brazil. PeerJ 59.5 21 Prophylactic thyroidectomy in pediatric multiple endocrine neoplasia type 2: A single-institution case series. International journal of pediatric otorhinolaryngology 56.5 22 Hereditary Predisposition to Acute Myeloid Leukemia: A Novel Germline CEBPA Mutation in a Multigenerational Family. Case reports in hematology 63.5 23 Diagnostic yield of cancer predisposition in a nationwide prospective childhood acute leukemia cohort. Nature communications 62.4 24 Semaglutide for Treating Paediatric Craniopharyngioma-Related Obesity: A Multicentre Case Series. Diabetes, obesity & metabolism 74.2 25 Individualized Patient Education Using Virtual Reality to Prepare Families for Solid Tumor Surgery in Pediatric Oncology. Pediatric blood & cancer 59.9 26 Language, Culture, and Cancer: Qualitative Insights Into Communication Disparities Among Spanish-Speaking Caregivers of Children With Cancer. Pediatric blood & cancer 57.2 27 Analysis of Epstein-Barr Virus and Tumor-Derived Circulating Plasma DNA in Children and Young Adults With Classical Hodgkin Lymphoma in East Africa. Pediatric blood & cancer 61.2 28 Use of dietary supplements and over-the-counter products among adults with a self-reported history of cancer in Poland. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 59.9 29 Machine learning and computational approaches to model therapeutic response and resistance in diffuse midline glioma. Journal of neuro-oncology 66.76 30 Predicting early recurrence of craniopharyngioma using multi-omics radiomic modeling: a retrospective cohort study. Neurosurgical review 67.0 31 Beyond Nerve Hyperexcitability: Potential Implications of Cerebrospinal Fluid CASPR2 Antibodies for Central Pain Processing in Isaacs Syndrome: A Case-Based Systematic Review. Pain and therapy 78.5 32 Definitive surgical outcomes in children with advanced hepatoblastoma (PRETEXT III-IV): A retrospective single-center canadian experience. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 68.5
PATIENT-FRIENDLY SUMMARY

Early Discontinuation of Empiric Antibiotic Therapy in Children with Cancer and Febrile Neutropenia: A Narrative Review.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic